Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Imnovid (previously Pomalidomide Celgene)“
Suchtreffer
Begriffe & Kennungen
Imnovid (previously Pomalidomide Celgene) · 4.8 · 18 Haemorrhage Haemorrhagic disorders have been reported with pomalidomide, especially in patients with risk f
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Adverse reactions tended to occur more frequently within the first 2 cycles of treatment with pomalidomide.
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Allergic reactions and severe skin reactions Angioedema, anaphylactic reaction and severe cutaneous reactions
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Description of selected adverse reactions
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Febrile neutropenia (FN) was reported in 3.2% (Pom+Btz+Dex) patients and 6.7% (Pom+Dex) patients and was serio
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Frequencies are defined in accordance with current guidance, as: very common (≥ 1/10), common (≥ 1/100 to < 1/
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Infection Infection was the most common non haematological toxicity.
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Infection occurred in 83.1% (Pom+Btz+Dex) patients and 55.0% (Pom+Dex) patients (34.9% (Pom+Btz+Dex) and 24.0%
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Neutropenia and thrombocytopenia tended to occur more frequently within the first 2 cycles of treatment with p
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Paediatric population Adverse reactions reported in paediatric patients (aged 4 to 18 years) with recurrent or
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Peripheral neuropathy - Pomalidomide in combination with bortezomib and dexamethasone Patients with ongoing pe
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Peripheral neuropathy - Pomalidomide in combination with dexamethasone Patients with ongoing peripheral neurop
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Pomalidomide in combination with bortezomib and dexamethasone The most commonly reported blood and lymphatic s
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Pomalidomide in combination with dexamethasone The most commonly reported adverse reactions in clinical studie
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Summary of the safety profile
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Table 7. Adverse reactions (ADRs) reported in clinical trials and post-market settings Combination of treatmen
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenImnovid (previously Pomalidomide Celgene) · 4.8 · Teratogenicity Pomalidomide is structurally related to thalidomide. Thalidomide is a known human teratogenic a
Eintrag öffnen